Medicare Reimbursement: 2019 CLFS Offers Some PAMA Relief But Not Nearly Enough

Email not displaying correctly? View it in your browser.

November 20, 2018

FOCUS ON
Medicare Reimbursement: 2019 CLFS Offers Some PAMA Relief But Not Nearly Enough
From - National Intelligence Report
The battle between CMS and the lab industry over Medicare Part B pricing for lab tests is intensifying notwithstanding the…
Read More

		INDUSTRY TRENDS One-Fourth of Myriad's Variants of Unknown Significance Reclassified Over 10 Years From - Diagnostic Testing & Emerging Technologies Variant reclassification following hereditary cancer genetic testing is common, according to a study published by… Read More

FEE SCHEDULES
Reimbursement Trends: Part B Medicare Lab Payments Up Slightly in 2017
From - G2 Compliance Advisor
According to a new OIG report, Clinical Laboratory Fee Schedule payments for lab tests in…
Read More

INDUSTRY BUZZ
FDA Watch: Changes to CBER Email Policy May Affect Your Lab
From - Laboratory Industry Report
Heads up to any lab that's subject to oversight by the CBER, i.e., the FDA agency responsible for regulating biological products for human use…
Read More

For questions concerning delivery of this email, please contact customer service at:
(888) 729-2315 | customerservice@plainlanguagemedia.com